tiprankstipranks
ImmunityBio (IBRX)
NASDAQ:IBRX

ImmunityBio (IBRX) Stock Investors

975 Followers
Based on 743,298 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold IBRX
On average, investors allocate 5.01% of their portfolios to IBRX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 743,298 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding IBRX

<0.1%
Last 7
Days
8.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding IBRX, out of 743,298 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

IBRX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.51%
$4.82
Increased
<0.01%
$6.20
Reduced
0.00%
$8.54
Based on the activity of 14,068 investors who made their portfolios public
The table shows changes in IBRX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

IBRX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.75%
-0.58%
-1.48%
33.50B
Consumer Cyclical
Riot Platforms
4.87%
-0.52%
-1.58%
2.64B
Financial
Bristol-Myers Squibb
3.23%
-0.24%
+0.96%
84.19B
Healthcare
ChargePoint Holdings
4.00%
-0.57%
-2.40%
642.21M
Consumer Cyclical
Marathon Digital Holdings
5.54%
-0.51%
-1.50%
5.42B
Financial
GE Aerospace
5.29%
-0.38%
+0.17%
174.01B
Industrials
PDD Holdings
4.92%
-0.55%
+4.84%
176.64B
Consumer Cyclical
Plug Power
4.97%
-1.05%
-3.34%
1.73B
Industrials
Coherus Biosciences
2.58%
-1.31%
-5.01%
198.48M
Healthcare
Merck & Company
3.93%
-0.12%
+2.68%
313.56B
Healthcare
Based on the activity of 743,298 active portfolios
Open your Smart Portfolio

IBRX Investor Analysis

IBRX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.6%
of IBRX holders
are under 35
Average Segment Performance
Average P/E Ratio21.46
Beta7.39
Dividend Yield6.06%
IBRX investors between 35–55

Between 35–55

9.1%
Last 30 days
Holdings Change
50.7%
of IBRX holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.66
Beta13.51
Dividend Yield6.08%
IBRX investors over 55

Over 55

3.8%
Last 30 days
Holdings Change
37.7%
of IBRX holders
are over 55
Average Segment Performance
Average P/E Ratio20.71
Beta4.77
Dividend Yield7.20%
Overview of age group and performance of IBRX stock investors
See who invests in IBRX according to age group and performance.

FAQ

How many retail Investors hold IBRX?
<0.1% of TipRanks' retail investors hold IBRX in their portfolios.
    What is IBRX Investor Sentiment?
    IBRX’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of IBRX in the last 7 days?
      <0.1% of TipRanks' retail investors changed their holding of IBRX in the last 7 days.
        What percentage of retail investors changed their holding of IBRX in the last 30 days?
        ▲ 8.5% of TipRanks' retail investors changed their holding of IBRX in the last 30 days.
          What is the average age of retail investors who hold IBRX?
          The average age of IBRX Holders is between 35–55.
            What other stocks have IBRX investors also bought?
            IBRX Investors also bought DKNG, RIOT, BMY, CHPT, MARA, GE, PDD, PLUG, CHRS, MRK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AZNAstraZeneca
              BCRXBioCryst
              BSXBoston Scientific
              DVADaVita
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis